Industry experts are warning that political oversight of the independent Nuclear Regulatory Commission could do more harm than good.

The ‘president’s id’ is leaving his mark on domestic and foreign policy with knowledge acquired in Trump’s first term and power delegated in this term.

Tenn.,said the fate of the United States might rely on the ability of Congress to turn President Donald Trump’s executive orders into laws. “I fear that we will seriously lose

A curated selection of the top 10 logistics and supply chain stories from 2024, reflecting key trends and themes identified by LM Group News Editor Jeff Berman—offering insights beyond popularity metrics to spotlight… 2025 Logistics Technology ...

Shares of pharmaceutical companies declined after U.S. President Donald Trump announced plans to lower U.S. prescription drug prices to match those in other countries. In a post on Truth Social, Trump said that he would sign an executive order to reduce drug prices by 30% to 80%.

His executive order on citizenship drew intense scrutiny, but it has not yet taken effect. Many of his other policies have immediately upended the system.

White House counsel have instructed staff in the Office of Management and Budget to stop reviewing federal reduction-in-force and reorganization plans or discussing them with agencies in light of a recent court ruling.

Drafts of executive orders reportedly circulating within the White House reveal a potential sweeping overhaul of U.S. nuclear power policy, with the aim of quadrupling nuclear energy capacity by 2040.